Loading
STAT News
STAT News has the best-written reporting on the science and business of cancer, with real scepticism.
Overview
STAT News publishes health and biotech journalism across cancer science, drug pricing, policy and industry, with some of the best-written and most sceptical reporting on the science and business of cancer. It publishes daily from Boston Globe Media and is strong on radiopharmaceuticals, mRNA vaccines, access after approval and FDA politics. Access is freemium with a STAT+ subscription. On OnCo it is listed as a source with the tags source and news.
Holds
Health and biotech journalism: cancer science, drug pricing, policy, and industry.
Licence
Freemium; STAT+ subscription
Maintainer
Boston Globe Media
Connected
1Similar pages
- CollectionBioPharma Dive
Shares Nimbus Therapeutics and the tags source, news.
- CollectionADC Review
Shares the tags source, news.
- CollectionASCO Daily News
Shares the tags source, news.
- CollectionThe ASCO Post
Shares the tags source, news.
- CollectionBioCentury
Shares the tags source, news.
- CollectionThe Cancer Letter
Shares the tags source, news.
- CollectionCancerNetwork (ONCOLOGY)
Shares the tags source, news.
- CollectionEndpoints News
Shares the tags source, news.
companies
Sources
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
statnews.com · 1
A source that has moved or gone is reported by the weekly link check. /audit/